Beyond glycemic effects, GLP-1 receptor agonists act on receptors in the central nervous system, particularly in areas regulating appetite and food intake
Key Details: Eli Lilly launched its Employer Connect program in March 2026 with more than 15 independent partners, each offering a different model for employers to cover Zepbound
These medicines have been extensively examined in Novo Nordisks robust clinical development programs, including randomised controlled trials, which to date have not shown any observable treatment difference compared to placebo for macular degeneration or age-related macular degeneration
Carnitine, Glucose Utilization and Insulin Resistance Ive talked a lot in previous articles about how blood sugar imbalances are extremely common in Hashimotos
Fibroblasts adhere better to the damaged substrate, migrate to the repair zone, and produce more extracellular matrix (collagen, fibronectin)